Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
46,493,166
-
Shares change
-
+11,444,024
-
Total reported value, excl. options
-
$1,034,139,433
-
Value change
-
+$269,937,051
-
Put/Call ratio
-
42%
-
Number of buys
-
95
-
Number of sells
-
34
-
Price
-
$22.24
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q4 2020
As of 31 Dec 2020 Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) had 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 46,493,166 shares of stock of the company.
Largest 10 holders included Avidity Partners Management LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Nantahala Capital Management, LLC, and STATE STREET CORP.
This table shows 140 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.